Mannkind (MNKD) Change in Receivables (2015 - 2026)
Mannkind's (MNKD) quarterly Change in Receivables came in at -$10.3 million in Q1 2026, down 160.19% year-on-year from $17.1 million in Q1 2025, and down 1159.49% on a QoQ basis from -$817000.0 in Q4 2025.
Mannkind (MNKD) Change in Receivables (2015 - 2026) Analysis & Trends
Mannkind (MNKD) has 12 years of Change in Receivables data on file, last reported at -$10.3 million in Q1 2026.
- On a quarterly basis, Change in Receivables fell 160.19% year-over-year to -$10.3 million in Q1 2026; TTM through Mar 2026 was -$22.6 million, a 351.71% decrease from a year earlier, with the FY2025 full-year figure at $4.8 million, up 279.56% from the prior year.
- Change in Receivables for Q1 2026 stood at -$10.3 million, down from -$817000.0 in the prior quarter.
- Over the last five years, Change in Receivables for MNKD reached as high as $17.1 million in Q1 2025 and fell as low as -$10.3 million in Q1 2026.
- Historically, Change in Receivables has averaged $75411.8 across 5 years, with a median of -$817000.0 in 2025.
- Across the five-year window, Change in Receivables soared 848.68% in 2022 and tumbled 170.51% in 2023, its largest moves.
- Year by year, Change in Receivables stood at -$6.7 million in 2022, then fell by 10.07% to -$7.4 million in 2023, then grew by 13.39% to -$6.4 million in 2024, then surged by 87.19% to -$817000.0 in 2025, then slumped by 1159.49% to -$10.3 million in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were -$10.3 million in Q1 2026, -$817000.0 in Q4 2025, and -$9.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn | -10.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.29 Mn |
| Mar 31, 2026 | -10.29 Mn |
| Dec 31, 2025 | -817,000.00 |
| Dec 31, 2025 | -817,000.00 |
| Sep 30, 2025 | -9.76 Mn |
| Sep 30, 2025 | -9.76 Mn |
| Jun 30, 2025 | -1.76 Mn |
| Jun 30, 2025 | -1.76 Mn |
| Mar 31, 2025 | 17.10 Mn |
| Mar 31, 2025 | 17.10 Mn |
| Dec 31, 2024 | -6.38 Mn |
| Dec 31, 2024 | -6.38 Mn |
| Sep 30, 2024 | -5.16 Mn |
| Sep 30, 2024 | -5.16 Mn |
| Jun 30, 2024 | 3.43 Mn |
| Jun 30, 2024 | 3.43 Mn |
| Mar 31, 2024 | 5.46 Mn |
| Mar 31, 2024 | 5.46 Mn |
| Dec 31, 2023 | -7.37 Mn |
| Dec 31, 2023 | -7.37 Mn |